Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LULU vs GSK✓SelectedUSD · GSKLULU vs GSK performance historyLatest closeAs of-2.76%11/20
Stock and ETF performance explorer

LULU vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+633.0%
GSK return
+148.1%
Excess return
+484.9%
Maximum drawdown
-92.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.8%-0.1%-2.6%-2.7%
7D-2.9%-5.3%+2.5%-0.3%
30D+6.3%-3.7%+10.0%+8.2%
3M-11.3%-7.3%-4.0%-8.0%
6M-18.0%-4.2%-13.8%-16.5%
YTD-50.6%+0.9%-51.5%-51.3%
1Y-37.7%+7.3%-45.0%-40.4%
3Y-76.1%+52.7%-128.8%-81.8%
5Y-78.3%+40.1%-118.4%-83.1%
10Y+87.9%+98.7%-10.8%+14.1%
All+633.0%+148.1%+484.9%+222.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling